#patent cliff

Discover 2 curated intelligence briefings related to this specific topic.

Southeast Asia Just Cracked the Orphan Drug Cost Code
Technology & Innovation

Southeast Asia Just Cracked the Orphan Drug Cost Code

A strategic reorientation in Southeast Asian bio-manufacturing is slashing the cost of orphan drugs. By integrating modular GMP facilities and regulatory harmonization, the region is moving from generic biologics to high-value, low-volume rare disease breakthroughs.

Read Analysis
Biopharma is Trading Pills for Printed Organs
Technology & Innovation

Biopharma is Trading Pills for Printed Organs

As blockbuster drug patents expire, pharmaceutical giants are shifting capital toward 3D bioprinting to build a new, uncopyable moat of biological intellectual property.

Read Analysis